The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)
| dc.contributor.author | Piraino, Alessio | |
| dc.contributor.author | Brusselle, Guy | |
| dc.contributor.author | Grainge, Christopher | |
| dc.contributor.author | Roche, Nicolas | |
| dc.contributor.author | Gayle, Alicia | |
| dc.contributor.author | Carter, Victoria | |
| dc.contributor.author | Price, David | |
| dc.contributor.author | Di Palma, Luca | |
| dc.contributor.author | Singh, Dave | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2025-08-26T10:41:01Z | |
| dc.date.available | 2025-08-26T10:41:01Z | |
| dc.date.issued | 2025-05 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 2 | |
| dc.format.extent | 141720 | |
| dc.identifier | 308269858 | |
| dc.identifier | 77851089-da8f-49f4-b438-b8e602398e6c | |
| dc.identifier.citation | Piraino, A, Brusselle, G, Grainge, C, Roche, N, Gayle, A, Carter, V, Price, D, Di Palma, L & Singh, D 2025, 'The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)', American Journal of Respiratory and Critical Care Medicine, vol. 211, no. Abstracts, A1474. https://doi.org/10.1164/ajrccm.2025.211.Abstracts.A1474 | en |
| dc.identifier.doi | 10.1164/ajrccm.2025.211.Abstracts.A1474 | |
| dc.identifier.issn | 1073-449X | |
| dc.identifier.uri | https://hdl.handle.net/2164/25915 | |
| dc.identifier.vol | 211 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | American Journal of Respiratory and Critical Care Medicine | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G) | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Price_etal_ATS_The_BETRI_Study_AAM.pdf
- Size:
- 138.4 KB
- Format:
- Adobe Portable Document Format
